Why Agios Pharmaceuticals Inc (AGIO) Stock Is Rising
As of 2026-10-20, Agios Pharmaceuticals Inc (AGIO) has a next-year EPS growth estimate of 34.93%. Featured in our EPS revision report on 2026-10-20.
Why AGIO Stock Is Rising
- +EPS Estimate Upgraded: Analysts raised Agios Pharmaceuticals Inc's next-year EPS growth estimate from 34.91% to 34.93% on 2026-10-15.
- ·Current-Year Growth: Projected at 19.31%, supporting the forward estimate revision.
News Context
The primary structural driver is a modest upward EPS revision: on 2026-10-15, analysts
Generated 2026-10-20 · news as of 2026-10-20
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 34.93%
- EPS growth this year
- 19.31%
- EPS next quarter (est)
- -$1.24
- Last price
- $36.64
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-10-20 | 34.93% | 19.31% | -$1.24 | $36.64 |
| 2026-10-19 | 34.93% | 19.31% | -$1.24 | $34.90 |
| 2026-10-16 | 34.93% | 19.31% | -$1.24 | $31.32 |
| 2026-10-15 | 34.93% | 19.31% | -$1.24 | $32.32 |
| 2026-10-14 | 34.91% | 19.29% | -$1.24 | $30.97 |
| 2026-10-13 | 34.91% | 19.29% | -$1.24 | $30.21 |
| 2026-10-12 | 34.91% | 19.29% | -$1.24 | $30.82 |
| 2026-10-11 | 34.91% | 19.29% | -$1.24 | $31.81 |
| 2026-10-10 | 34.91% | 19.29% | -$1.24 | $31.81 |
| 2026-10-09 | 34.91% | 19.29% | -$1.24 | $31.81 |
| 2026-10-08 | 34.95% | 19.31% | -$1.24 | $31.92 |
| 2026-10-07 | 34.79% | 20.12% | -$1.22 | $31.79 |
| 2026-10-06 | 34.94% | 20.22% | -$1.21 | $31.72 |
| 2026-10-05 | 34.94% | 20.22% | -$1.21 | $31.25 |
| 2026-10-04 | 34.94% | 20.22% | -$1.21 | $31.80 |
| 2026-10-03 | 34.94% | 20.22% | -$1.21 | $31.80 |
| 2026-10-02 | 34.94% | 20.22% | -$1.21 | $31.80 |
| 2026-10-01 | 34.94% | 20.22% | -$1.21 | $32.48 |
| 2026-09-30 | 34.94% | 20.22% | -$1.21 | $33.25 |
| 2026-09-29 | 34.94% | 20.22% | -$1.21 | $33.30 |
| 2026-09-28 | 34.94% | 20.22% | -$1.21 | $33.42 |
| 2026-09-27 | 34.94% | 20.22% | -$1.21 | $32.58 |
| 2026-09-25 | 34.94% | 20.22% | -$1.21 | $32.58 |
| 2026-09-24 | 34.94% | 20.22% | -$1.21 | $32.90 |
| 2026-09-23 | 34.94% | 20.22% | -$1.21 | $34.19 |
| 2026-09-22 | 34.94% | 20.22% | -$1.21 | $34.97 |
| 2026-09-21 | 34.94% | 20.22% | -$1.21 | $33.95 |
| 2026-09-20 | 35.07% | 20.22% | -$1.21 | $33.07 |
| 2026-09-18 | 35.07% | 20.22% | -$1.21 | $33.07 |
| 2026-09-17 | 35.07% | 20.22% | -$1.21 | $33.61 |
Reports Featuring AGIO
Recent News
Screen Performance
Aggregate stats across all 2085 tickers our top-EPS-revision screen has flagged over the past 202 days.
- Median return since detection
- -2.4%
- % of tickers in the green
- 44%
- Median return on winners
- +22.3%
- Large revisions captured
- 1911
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
Why did Agios Pharmaceuticals Inc (AGIO) stock go up recently?▾
Agios Pharmaceuticals Inc (AGIO) stock has risen following an analyst upgrade of its next-year EPS growth estimate from 34.91% to 34.93% on 2026-10-15. EPS estimate upgrades are among the strongest leading indicators of stock outperformance.
What is Agios Pharmaceuticals Inc's next-year EPS growth estimate?▾
As of 2026-10-20, Agios Pharmaceuticals Inc (AGIO) has a next-year EPS growth estimate of 34.93%, based on analyst consensus.
When was the latest EPS estimate revision for AGIO?▾
The most recent revision occurred on 2026-10-15, when analysts adjusted the next-year EPS growth estimate from 34.91% to 34.93%.
What sector and industry does Agios Pharmaceuticals Inc belong to?▾
Agios Pharmaceuticals Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. AGIO appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Agios Pharmaceuticals Inc (AGIO) appears here because it was detected by our daily top-EPS-revision-performer screen.